Regeneron Pharmaceuticals Inc (REGN) — Cash Flow Reinvestment Rate
Regeneron Pharmaceuticals Inc (REGN) has a Cash Flow Reinvestment Rate of 0.35x as of March 2026, reinvesting $380.00 Million (capex $230.60 Million plus investments $-149.40 Million) from operating cash flow of $1.08 Billion. Explore Regeneron Pharmaceuticals Inc (REGN) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Regeneron Pharmaceuticals Inc Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Regeneron Pharmaceuticals Inc across 16 annual periods. Also explore REGN current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Regeneron Pharmaceuticals Inc (2006–2025)
Year-by-year capital reinvestment analysis for Regeneron Pharmaceuticals Inc. For live market cap and broader valuation context, see REGN market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | $1.49 Billion | $4.98 Billion | $898.40 Million | ▼ -59.1% |
| 2024 | 0.73x | $3.22 Billion | $4.42 Billion | $755.90 Million | ▼ -43.2% |
| 2023 | 1.28x | $5.90 Billion | $4.59 Billion | $926.40 Million | ▲ +154.9% |
| 2022 | 0.50x | $2.53 Billion | $5.01 Billion | $590.10 Million | ▼ -33.7% |
| 2021 | 0.76x | $5.38 Billion | $7.08 Billion | $551.90 Million | ▲ +71.8% |
| 2020 | 0.44x | $1.16 Billion | $2.62 Billion | $614.60 Million | ▼ -47.0% |
| 2019 | 0.83x | $2.03 Billion | $2.43 Billion | $429.60 Million | ▲ +26.1% |
| 2018 | 0.66x | $1.45 Billion | $2.20 Billion | $383.10 Million | ▼ -13.9% |
| 2017 | 0.77x | $1.01 Billion | $1.31 Billion | $272.60 Million | ▲ +9.2% |
| 2016 | 0.70x | $1.05 Billion | $1.49 Billion | $511.90 Million | ▲ +3.3% |
| 2015 | 0.68x | $907.60 Million | $1.33 Billion | $677.93 Million | ▲ +22.0% |
| 2014 | 0.56x | $420.78 Million | $752.43 Million | $333.01 Million | ▼ -7.4% |
| 2013 | 0.60x | $355.45 Million | $588.60 Million | $156.32 Million | ▼ -86.4% |
| 2010 | 4.44x | $428.21 Million | $96.34 Million | $99.69 Million | ▲ +559.5% |
| 2007 | 0.67x | $18.45 Million | $27.37 Million | $18.45 Million | ▲ +453.2% |
| 2006 | 0.12x | $2.81 Million | $23.07 Million | $2.81 Million | — |